ArticleFrontiers in endocrinology2020

IGFBP-1 Expression Promotes Tamoxifen Resistance in Breast Cancer Cells via Erk Pathway Activation.

Yan Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.